This is the area with the strongest evidence and the most options in 2026
Knock-off versions of Eli Lilly's retatrutide, hailed as a potential 'new Ozempic', are being sold directly to US consumers Eli Lilly sparked enthusiasm about the future of retatrutide when it announced in June that Phase 2 trial results showed the drug led to an average weight loss of up to 24% over 48 weeks Eli Lilly sparked enthusiasm about the future of retatrutide when it announced in June that Phase 2 trial results showed the drug led to an average weight loss of up to 24% over 48 weeks
Fiber becomes extra important too
The increased population of Akkermansia suggests that Solnul may help enhance gut barrier integrity and metabolic functions, such as blood sugar regulation and weight management, through its prebiotic effects, which encourage the growth of beneficial gut bacteria
"I saw my friends using [GLP-1's], saw a lot of people on it, and I tried it, and it actually worked." She told People that she has lost over 31 pounds since she used Zepbound for additional weight loss support
Revenue Concentration (Fig